SpliceBio’s SB-007 Cleared By FDA For Stargardt Disease Phase 1/2 Trial
12 Dec 2024 //
PR NEWSWIRE
SpliceBio sparks eye disease gene therapy collab with Roche unit
17 Oct 2023 //
FIERCE BIOTECH
12 Dec 2024 //
PR NEWSWIRE
17 Oct 2023 //
FIERCE BIOTECH